Jianhua H. Zheng
Harbin, 150001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
A multicenter, randomized, open and positive parallel controlled clinical study of clotrimazole vaginal expansion suppository and vaginal tablet in the treatment of mild and moderate vulvovaginal candidiasis
Journal: Zhonghua fu chan ke za zhi
Published: October 29, 2020
Knockdown of BAG3 synergizes with olaparib to kill ovarian cancer cells via repressing autophagy.
Journal: Journal of investigative medicine : the official publication of the American Federation for Clinical Research
Published: October 27, 2020
Polypeptide LTX-315 reverses the cisplatin chemoresistance of ovarian cancer cells via regulating Beclin-1/PI3K/mTOR signaling pathway.
Journal: Journal of biochemical and molecular toxicology
Published: June 30, 2020
Lowly-expressed lncRNA GAS5 facilitates progression of ovarian cancer through targeting miR-196-5p and thereby regulating HOXA5.
Journal: Gynecologic oncology
Published: May 02, 2018
Lysine-Specific Demethylase 1 (LSD1) Inhibitor S2101 Induces Autophagy via the AKT/mTOR Pathway in SKOV3 Ovarian Cancer Cells.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: December 04, 2016
Paclitaxel plus nedaplatin vs. paclitaxel plus carboplatin in women with epithelial ovarian cancer: A multi-center, randomized, open-label, phase III trial.
Journal: Oncology letters
Published: June 08, 2016
Role of Wnt/β-catenin, Wnt/c-Jun N-terminal kinase and Wnt/Ca2+ pathways in cisplatin-induced chemoresistance in ovarian cancer.
Journal: Experimental and therapeutic medicine
Published: March 27, 2016
TMPRSS3 modulates ovarian cancer cell proliferation, invasion and metastasis.
Journal: Oncology reports
Published: June 03, 2015
Interference with the expression of β-catenin reverses cisplatin resistance in A2780/DDP cells and inhibits the progression of ovarian cancer in mouse model.
Journal: DNA and cell biology
Published: September 12, 2014
MiR-25 promotes ovarian cancer proliferation and motility by targeting LATS2.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: June 30, 2014
CDK2 and CDK4 play important roles in promoting the proliferation of SKOV3 ovarian carcinoma cells induced by tumor-associated macrophages.
Journal: Oncology reports
Published: January 16, 2014
Last Updated: 09/26/2026